Search Results 251-260 of 13914 for anti-TNF drugs

1. L-arginine - Mayo Clinic

   Anticoagulants and anti-platelet drugs, herbs and supplements. These types of drugs, herbs and supplements reduce blood clotting. Taking L-arginine with ...

2. Artemether and lumefantrine (oral route) - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors - Mayo Clinic

   An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid ...

4. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living ... Patient must receive anti-TNF treatment within 2 months following enrollment into the registry.

5. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Drugs & Supplements A-Z · Health ... Is naïve to biologic therapy (TNF antagonists or vedolizumab) ... anti-tumor necrosis factors (TNFs) for at least 8 weeks.

6. Mayo Clinic: Two-Drug Combination May Slow Deadly Thyroid Cancer

   Paclitaxel was added to address the aggressiveness of anaplastic thyroid cancer tumors and bolster anti-cancer effects. The team investigated how the two drugs ...

7. Overview - Pharmacogenomics and Drug Targets Laboratory - Mayo Clinic Research

   Most anti-neoplastic drugs have narrow therapeutic indices. Therefore, treatment with these drugs can result in significant, sometimes, life-threatening ...

8. Ustekinumab-ttwe (intravenous route, subcutaneous route) - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

9. A Study to Evaluate Posaconazole to Treat Genetically-defined Patients with Active Crohn's Disease - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search ... anti-TNF, anti IL12/23, or anti-integrin therapy ...

10. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Demonstrated intolerance or inadequate response to one or more anti-tumor necrosis factor (TNF) therapies. Exclusion Criteria: Current diagnosis of ...